Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmicals 已獲得歐洲專利號 EP3538158，標題爲 “纖維化治療（包括抑制纖維化疾病和與 NAFLD 和 NASH 相關的肝纖維化疾病的方法）”
Galmed Pharmaceuticals Has Been Granted European Patent Number EP3538158 Titled "Treatment For Fibrosis (Including Methods For Inhibition Of Fibrotic Disorders And Hepato-Fibrotic Conditions Associated With NAFLD And NASH)"
Galmed Pharmicals 已獲得歐洲專利號 EP3538158，標題爲 “纖維化治療（包括抑制纖維化疾病和與 NAFLD 和 NASH 相關的肝纖維化疾病的方法）”